Dr. Naureen Memon

Naureen Memon, MD, is a dedicated neonatologist who has been in clinical practice for over 15 years. Board-certified in pediatrics and neonatal-perinatal medicine by the American Board of Pediatrics, she is committed to providing high-quality and evidence-based care for newborns and young infants, has a strong interest in medical education and research, is the associate program director of the neonatal-perinatal medicine fellowship program at Goryeb Children’s Hospital (GCH), Atlantic Health System, and serves on several residency committees at GCH, including the Goryeb Academic Pediatric Support (GAPS) committee. Dr. Memon received her BA, summa cum laude, from the University of Pennsylvania, Philadelphia, PA, and earned her medical degree from Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, where she graduated at the top of her class. She completed her residency in pediatrics at Massachusetts General Hospital, Harvard Medical School, Boston, MA. After residency, she practiced as a general pediatrician and pediatric hospitalist for a couple years before returning to Rutgers Robert Wood Johnson Medical School, where she completed her fellowship in neonatal-perinatal medicine. She joined Atlantic Health System in 2016.Dr. Memon’s research interests are broadly focused on understanding neonatal intestine and liver function, and she has significant experience in various cellular and animal models designed to investigate pathways associated with the disturbance of bilirubin, bile acid, and lipid metabolism. She has authored multiple peer-reviewed publications, presented at numerous national and international conferences, is the founder and director of the Neonatal Intestinal Rehabilitation Team (NIRT) at GCH, a multidisciplinary group that helps manage the care of infants with prolonged intestinal failure, and is co-chair of the Pediatric Pharmacy and Therapeutics Committee at GCH. She is a participating provider of the Atlantic Accountable Care Organization.

Her clinical expertise encompasses Transient Familial Hyperbilirubinemia, Trophoblastic Tumor Placental Site, Premature Infant, and Patent Ductus Arteriosus.

Dr. Memon is board certified in American Board Of Pediatrics. She is actively involved in clinical research, co-authoring 17 peer reviewed articles. Dr. Memon is currently accepting new patients.